Scientific Opinion on the substantiation of a health claim related to isolated soy protein and reduction of blood LDL-cholesterol concentrations pursuant to Article 14 of Regulation (EC) No 1924/2006

EFSA Journal

Volumn 10, Issue 2, 2012, Pages

[No Author Info available]

Author keywords

blood cholesterol; health claims; Isolated soy protein; ISP; LDL cholesterol

Indexed keywords

EID: 85078375574     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2012.2555     Document Type: Article

References (63)

1. Allen JK, Becker DM, Kwiterovich PO, Lindenstruth KA and Curtis C, 2007. Effect of soy protein-containing isoflavones on lipoproteins in postmenopausal women. Menopause, 14, 106–114.
2. Anderson JW, Johnstone BM and Cook-Newell ME, 1995. Meta-analysis of the effects of soy protein intake on serum lipids. New England Journal of Medicine, 333, 276–282.
3. Anderson JW and Bush HM, 2011. Soy protein effects on serum lipoproteins: a quality assessment and meta-analysis of randomized, controlled studies. Journal of the American College of Nutrition, 30, 79–91.
4. Ashton E and Ball M, 2000. Effects of soy as tofu vs meat on lipoprotein concentrations. European Journal of Clinical Nutrition, 54, 14–19.
5. Balk E, Chung M, Chew P, Ip S, Raman G, Kupelnick B, Tatsioni A, Sun Y, Wolk B, DeVine D and Lau J, 2005. Effects of Soy on Health Outcomes. Evidence Report/Technology Assessment No. 126. (Prepared by Tufts-New England Medical Center Evidence-based Practice Center under Contract No. 290-02-0022.) AHRQ Publication No. 05-E024-2. Rockville, MD: Agency for Healthcare Research and Quality. August 2005.
6. Baum JA, Teng H, Erdman JW, Jr., Weigel RM, Klein BP, Persky VW, Freels S, Surya P, Bakhit RM, Ramos E, Shay NF and Potter SM, 1998. Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. American Journal of Clinical Nutrition, 68, 545–551.
7. Blum A, Lang N, Vigder F, Israeli P, Gumanovsky M, Lupovitz S, Elgazi A, Peleg A and Ben-Ami M, 2003. Effects of soy protein on endothelium-dependent vasodilatation and lipid profile in postmenopausal women with mild hypercholesterolemia. Clinical and Investigative Medicine, 26, 20–26.
8. Codex Alimentarius, 1989. General Standard for Soy Protein Products. CODEX STAN 175-1989, 3 pp.
9. Consonni A, Lovati MR, Manzoni C, Pizzagalli A, Morazzoni P and Duranti M, 2010. Cloning, yeast expression, purification and biological activity of a truncated form of the soybean 7S globulin alpha' subunit involved in Hep G2 cell cholesterol homeostasis. Journal of Nutritional Biochemistry, 21, 887–891.
10. Crouse JR, 3rd Morgan T, Terry JG, Ellis J, Vitolins M and Burke GL, 1999. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Archives of Internal Medicine, 159, 2070–2076.
11. Denke MA, 2005. Diet, lifestyle, and nonstatin trials: review of time to benefit. American Journal of Cardiology, 96, 3F–10F.
12. Duranti M, Lovati MR, Dani V, Barbiroli A, Scarafoni A, Castiglioni S, Ponzone C and Morazzoni P, 2004. The alpha' subunit from soybean 7S globulin lowers plasma lipids and upregulates liver beta-VLDL receptors in rats fed a hypercholesterolemic diet. Journal of Nutrition, 134, 1334–1339.
13. Evans M, Njike VY, Hoxley M, Pearson M and Katz DL, 2007. Effect of soy isoflavone protein and soy lecithin on endothelial function in healthy postmenopausal women. Menopause, 14, 141–149.
14. Gardner CD, Messina M, Kiazand A, Morris JL and Franke AA, 2007. Effect of two types of soy milk and dairy milk on plasma lipids in hypercholesterolemic adults: a randomized trial. Journal of the American College of Nutrition, 26, 669–677.
15. Gordon DJ, 2000. Cholesterol lowering reduces mortality: the statins. In: Cholesterol-Lowering Therapy: Evaluation of Clinical Trial Evidence. Ed Grundy SM. Marcel Dekker, New York, USA, 299–311.
16. Greany KA, Nettleton JA, Wangen KE, Thomas W and Kurzer MS, 2004. Probiotic consumption does not enhance the cholesterol-lowering effect of soy in postmenopausal women. Journal of Nutrition, 134, 3277–3283.
17. Harland JI and Haffner TA, 2008. Systematic review, meta-analysis and regression of randomised controlled trials reporting an association between an intake of circa 25 g soya protein per day and blood cholesterol. Atherosclerosis, 200, 13–27.
18. Ho SC, Woo JL, Leung SS, Sham AL, Lam TH and Janus ED, 2000. Intake of soy products is associated with better plasma lipid profiles in the Hong Kong Chinese population. Journal of Nutrition, 130, 2590–2593.
19. Ho SY, Schooling M, Hui LL, McGhee SM, Mak KH and Lam TH, 2006. Soy consumption and mortality in Hong Kong: proxy-reported case-control study of all older adult deaths in 1998. Preventive Medicine, 43, 20–26.
20. Hoie LH, Graubaum HJ, Harde A, Gruenwald J and Wernecke KD, 2005a. Lipid-lowering effect of 2 dosages of a soy protein supplement in hypercholesterolemia. Advances in Therapy, 22, 175–186.
21. Hoie LH, Morgenstern EC, Gruenwald J, Graubaum HJ, Busch R, Luder W and Zunft HJ, 2005b. A double-blind placebo-controlled clinical trial compares the cholesterol-lowering effects of two different soy protein preparations in hypercholesterolemic subjects. European Journal of Nutrition, 44, 65–71.
22. Hoie LH, Guldstrand M, Sjoholm A, Graubaum HJ, Gruenwald J, Zunft HJ and Lueder W, 2007. Cholesterol-lowering effects of a new isolated soy protein with high levels of nondenaturated protein in hypercholesterolemic patients. Advances in Therapy, 24, 439–447.
23. Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA, Ryder JJ, Hall WL and Cassidy A, 2008. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. American Journal of Clinical Nutrition, 88, 38–50.
24. Jenkins DJ, Kendall CW, Vidgen E, Vuksan V, Jackson CJ, Augustin LS, Lee B, Garsetti M, Agarwal S, Rao AV, Cagampang GB and Fulgoni V, 3rd 2000. Effect of soy-based breakfast cereal on blood lipids and oxidized low-density lipoprotein. Metabolism: Clinical and Experimental, 49, 1496–1500.
25. Jenkins DJ, Mirrahimi A, Srichaikul K, Berryman CE, Wang L, Carleton A, Abdulnour S, Sievenpiper JL, Kendall CW and Kris-Etherton PM, 2010. Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms. Journal of Nutrition, 140, 2302S–2311S.
26. Katan MB, Grundy SM, Jones P, Law M, Miettinen T and Paoletti R, 2003. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clinic Proceedings, 78, 965–978.
27. Kokubo Y, Iso H, Ishihara J, Okada K, Inoue M and Tsugane S, 2007. Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: the Japan Public Health Center-based (JPHC) study cohort I. Circulation, 116, 2553–2562.
28. Kreijkamp-Kaspers S, Kok L, Grobbee DE, de Haan EH, Aleman A, Lampe JW and van der Schouw YT, 2004. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA, 292, 65–74.
29. Law M, 2000. Plant sterol and stanol margarines and health. BMJ (Clinical Research Ed.), 320, 861–864.
30. Liu KS, 1997. Soybeans: Chemistry, Technology and Utilization. Chapman and Hall, New York, USA.
31. Lovati MR, Manzoni C, Gianazza E, Arnoldi A, Kurowska E, Carroll KK and Sirtori CR, 2000. Soy protein peptides regulate cholesterol homeostasis in Hep G2 cells. Journal of Nutrition, 130, 2543–2549.
32. Maesta N, Nahas EA, Nahas-Neto J, Orsatti FL, Fernandes CE, Traiman P and Burini RC, 2007. Effects of soy protein and resistance exercise on body composition and blood lipids in postmenopausal women. Maturitas, 56, 350–358.
33. Maki KC, Butteiger DN, Rains TM, Lawless A, Reeves MS, Schasteen C and Krul ES, 2010. Effects of soy protein on lipoprotein lipids and fecal bile acid excretion in men and women with moderate hypercholesterolemia. Journal of Clinical Lipidology, 4, 531–542.
34. Matthan NR, Jalbert SM, Ausman LM, Kuvin JT, Karas RH and Lichtenstein AH, 2007. Effect of soy protein from differently processed products on cardiovascular disease risk factors and vascular endothelial function in hypercholesterolemic subjects. American Journal of Clinical Nutrition, 85, 960–966.
35. McVeigh BL, Dillingham BL, Lampe JW and Duncan AM, 2006. Effect of soy protein varying in isoflavone content on serum lipids in healthy young men. American Journal of Clinical Nutrition, 83, 244–251.
36. Meyer BJ, Larkin TA, Owen AJ, Astheimer LB, Tapsell LC and Howe PR, 2004. Limited lipid-lowering effects of regular consumption of whole soybean foods. Annals of Nutrition and Metabolism, 48, 67–78.
37. Nagata C, Takatsuka N, Kurisu Y and Shimizu H, 1998. Decreased serum total cholesterol concentration is associated with high intake of soy products in Japanese men and women. Journal of Nutrition, 128, 209–213.
38. Nagata C, Takatsuka N and Shimizu H, 2002. Soy and fish oil intake and mortality in a Japanese community. American Journal of Epidemiology, 156, 824–831.
39. Ornish D, Scherwitz LW, Billings JH, Brown SE, Gould KL, Merritt TA, Sparler S, Armstrong WT, Ports TA, Kirkeeide RL, Hogeboom C and Brand RJ, 1998. Intensive lifestyle changes for reversal of coronary heart disease. JAMA, 280, 2001–2007.
40. Pedersen TR, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Holme I, Larsen ML, Bendiksen FS, Lindahl C, Szarek M and Tsai J, 2005. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. JAMA, 294, 2437–2445.
41. Radhakrishnan G, Rashmi, Agarwal N and Vaid NB, 2009. Isoflavone Rich Soy Protein Supplementation For Postmenopausal Therapy. Pakistan Journal of Nutrition, 8, 1009–1017.
42. Reynolds K, Chin A, Lees KA, Nguyen A, Bujnowski D and He J, 2006. A meta-analysis of the effect of soy protein supplementation on serum lipids. American Journal of Cardiology, 98, 633–640.
43. Rosell MS, Appleby PN, Spencer EA and Key TJ, 2004. Soy intake and blood cholesterol concentrations: a cross-sectional study of 1033 pre- and postmenopausal women in the Oxford arm of the European Prospective Investigation into Cancer and Nutrition. American Journal of Clinical Nutrition, 80, 1391–1396.
44. Sagara M, Kanda TM NJ, Teramoto T, Armitage L, Birt N, Birt C and Yamori Y, 2003. Effects of dietary intake of soy protein and isoflavones on cardiovascular disease risk factors in high risk, middle-aged men in Scotland. Journal of the American College of Nutrition, 23, 85–91.
45. Santo AS, Cunningham AM, Alhassan S, Browne RW, Burton H, Leddy JJ, Grandjean PW, Horvath SM and Horvath PJ, 2008. NMR analysis of lipoprotein particle size does not increase sensitivity to the effect of soy protein on CVD risk when compared with the traditional lipid profile. Applied Physiology, Nutrition, and Metabolism, 33, 489–500.
46. Solae LLC, 2008, unpublished. Evidence Based Review: Soy Protein and Coronary Heart Disease Health Claim.
47. Steinberg FM, Guthrie NL, Villablanca AC, Kumar K and Murray MJ, 2003. Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women. American Journal of Clinical Nutrition, 78, 123–130.
48. Takatsuka N, Nagata C, Kurisu Y, Inaba S, Kawakami N and Shimizu H, 2000. Hypocholesterolemic effect of soymilk supplementation with usual diet in premenopausal normolipidemic Japanese women. Preventive Medicine, 31, 308–314.
49. Taku K, Umegaki K, Sato Y, Taki Y, Endoh K and Watanabe S, 2007. Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials. American Journal of Clinical Nutrition, 85, 1148–1156.
50. Teede HJ, Dalais FS, Kotsopoulos D, Liang YL, Davis S and McGrath BP, 2001. Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. Journal of Clinical Endocrinology and Metabolism, 86, 3053–3060.
51. Teede HJ, Dalais FS, Kotsopoulos D, McGrath BP, Malan E, Gan TE and Peverill RE, 2005. Dietary soy containing phytoestrogens does not activate the hemostatic system in postmenopausal women. Journal of Clinical Endocrinology and Metabolism, 90, 1936–1936.
52. Teixeira SR, Potter SM, Weigel R, Hannum S, Erdman JW, Jr. and Hasler CM, 2000. Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men. American Journal of Clinical Nutrition, 71, 1077–1084.
53. Thorp AA, Howe PR, Mori TA, Coates AM, Buckley JD, Hodgson J, Mansour J and Meyer BJ, 2008. Soy food consumption does not lower LDL cholesterol in either equol or nonequol producers. American Journal of Clinical Nutrition, 88, 298–304.
54. Van Horn L, Liu K, Gerber J, Garside D, Schiffer L, Gernhofer N and Greenland P, 2001. Oats and soy in lipid-lowering diets for women with hypercholesterolemia: is there synergy? Journal of the American Dietetic Association, 101, 1319–1325.
55. Van Horn L, McCoin M, Kris-Etherton PM, Burke F, Carson JA, Champagne CM, Karmally W and Sikand G, 2008. The evidence for dietary prevention and treatment of cardiovascular disease. Journal of the American Dietetic Association, 108, 287–331.
56. Washburn S, Burke GL, Morgan T and Anthony M, 1999. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause, 6, 7–13.
57. Weggemans RM and Trautwein EA, 2003. Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis. European Journal of Clinical Nutrition, 57, 940–946.
58. West SG, Hilpert KF, Juturu V, Bordi PL, Lampe JW, Mousa SA and Kris-Etherton PM, 2005. Effects of including soy protein in a blood cholesterol-lowering diet on markers of cardiac risk in men and in postmenopausal women with and without hormone replacement therapy. Journal of Women's Health, 14, 253–262.
59. WHO (World Health Organization), 2002. World Health Report - Reducing Risks, Promoting Healthy Life.
60. Zhan S and Ho SC, 2005. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. American Journal of Clinical Nutrition, 81, 397–408.
61. Zhang B, Chen YM, Huang LL, Zhou XX, Chen CG, Ye YB and Su YX, 2008. Greater habitual soyfood consumption is associated with decreased carotid intima-media thickness and better plasma lipids in Chinese middle-aged adults. Atherosclerosis, 198, 403–411.
62. Zhang X, Shu XO, Gao YT, Yang G, Li Q, Li H, Jin F and Zheng W, 2003. Soy food consumption is associated with lower risk of coronary heart disease in Chinese women. Journal of Nutrition, 133, 2874–2878.
63. Zhuo XG, Melby MK and Watanabe S, 2004. Soy isoflavone intake lowers serum LDL cholesterol: a meta-analysis of 8 randomized controlled trials in humans. Journal of Nutrition, 134, 2395–2400.